Thornton J, Todd N J, Webster N R
Intensive Care Unit, St James's University Hospital, Leeds.
Anaesthesia. 1996 Nov;51(11):1018-20. doi: 10.1111/j.1365-2044.1996.tb14994.x.
A randomized controlled clinical trial was undertaken to evaluate the efficacy of antibiotic bonded lines in the reduction of central venous catheter infection. One hundred and seventy-six plain and bonded catheters were inserted into one hundred and ten patients in an intensive care unit, many of whom were admitted with evidence of sepsis. The catheters used in the study group, which had been pre-treated by the manufacturers with the cationic surfactant tridodecylmethylammonium chloride, were bonded with vancomycin 1 g made up in 10 ml of water immediately prior to insertion. The catheters used in the control group were neither pre-treated nor bonded with vancomycin. Eighty percent of control group catheters were infected compared with 62% of study catheters (p = 0.01). The most common organism isolated was coagulase negative staphylococcus. We conclude that antibiotic bonding can reduce central venous catheter infection even in a patient population with a high incidence of sepsis.
开展了一项随机对照临床试验,以评估抗生素涂层导管在降低中心静脉导管感染方面的疗效。在重症监护病房,将176根普通导管和涂层导管插入110例患者体内,其中许多患者入院时就有败血症迹象。研究组使用的导管由制造商预先用阳离子表面活性剂三(十二烷基)甲基氯化铵处理过,在插入前立即与1克万古霉素溶于10毫升水制成的溶液进行涂层处理。对照组使用的导管既未预先处理,也未用万古霉素涂层。对照组导管80%发生感染,而研究组导管为62%(p = 0.01)。分离出的最常见病原体是凝固酶阴性葡萄球菌。我们得出结论,即使在败血症发病率高的患者群体中,抗生素涂层也能减少中心静脉导管感染。